Advantage Trust Company’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Advantage Trust Company's LLY Position: Q3 2026 in Review
Advantage Trust Company held its Eli Lilly (LLY) position steady in Q3 2026 at 865 shares worth $1M. The position accounts for 0.35% of the portfolio, ranked #25.
Advantage Trust Company first reported a position in LLY in Q4 2023 and has held it in 12 quarters since. The position peaked at $1.04M in Q2 2026. 4,624 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Advantage Trust Company held 865 shares of Eli Lilly worth $1M as of Q3 2026.
- Advantage Trust Company left its Eli Lilly share count unchanged in Q3 2026.
- Eli Lilly made up 0.35% of Advantage Trust Company's portfolio in Q3 2026, its #25 holding.
- Advantage Trust Company first reported a position in Eli Lilly in Q4 2023 and has held it in 12 quarters since.
- Advantage Trust Company's Eli Lilly position peaked at $1.04M in Q2 2026.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Advantage Trust Company's 13F filing for Q3 2026, filed 19 Oct 2026.